Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
They are a sign that it is working
Everything else comes out of pocket
- $299.00 charged
This study found that weight loss induced by GLP-1 agonists led to improved pain and functional scores, reduced reliance on pain medications, and less frequent need for cortisone injections in people with knee arthritis
Read our guide to microdosing tirzepatide, or compare starting doses side by side in the GLP-1 microdosing dose chart
Filingeri noted that this research study was designed to further examine changes in weight, body fat mass, and muscle mass in patients taking incretin medications. We found that, under close supervision and regular follow-up from an obesity medicine specialist, patients were able to lose fat mass with only a minimal decline in muscle mass. Alexandra Filingeri, DCN, RCN Filingeri pointed out that the results of this study cannot be generalized to patients receiving medication via telemedicine without routine body composition analysis, nor can they be generalized to in-person visits without utilizing body composition analysis
